Rapid assay of stem cell functionality and potency using electric cell-substrate impedance sensing

• Published in: Stem cell research & therapy Vol. 6; no. 1; p. 192
• Main Authors: Rutten, Michael J, Laraway, Bryan, Gregory, Cynthia R, Xie, Hua, Renken, Christian, Keese, Charles, Gregory, Kenton W
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 05.10.2015; BioMed Central
• Subjects: Animals; Cell Movement; Electric Impedance; Humans; Jurkat Cells; Leukocytes, Mononuclear - physiology; Male; Method; Physiological aspects; Stem cells; Stem Cells - physiology; Swine; Swine, Miniature
• ISSN: 1757-6512; 1757-6512
• DOI: 10.1186/s13287-015-0182-2

Regenerative medicine studies using autologous bone marrow mononuclear cells (BM-MNCs) have shown improved clinical outcomes that correlate to in vitro BM-MNC invasive capacity. The current Boyden-chamber assay for testing invasive capacity is labor-intensive, provides only a single time point, and takes 36 hours to collect data and results, which is not practical from a clinical cell delivery perspective. To develop a rapid, sensitive and reproducible invasion assay, we employed Electric Cell-substrate Impedance Sensing (ECIS) technology. Chemokine-directed BM-MNC cell invasion across a Matrigel-coated Transwell filter was measurable within minutes using the ECIS system we developed. This ECIS-Transwell chamber system provides a rapid and sensitive test of stem and progenitor cell invasive capacity for evaluation of stem cell functionality to provide timely clinical data for selection of patients likely to realize clinical benefit in regenerative medicine treatments. This device could also supply robust unambiguous, reproducible and cost effective data as a potency assay for cell product release and regulatory strategies.